Bonne Santé Group adds new CFO

Health and wellness products producer Bonne Santé Group has appointed Alan Bergman to its chief financial officer position. The company specializes in nutraceutical products through its Bonne Santé  Natural Manufacturing company, a private label and contract manufacturing platform that operates out of a 22,000-sq.-ft.-facility in Doral, Fla.

Bergman brings to BSC a career in public and private sector finance, previously working at Deloitte & Touche, Weinberg & Co., Latitude Solutions, Woodfield Distribution, Greenlane Holdings, Bright Mountain Media and more.

He’s also an adjunct professor of accounting at Florida Atlantic University and Millennia Atlantic University.

"As Bonne Santé Group is on a path to public status in 2021, Alan's deep public company experience is invaluable in the execution of our strategic initiatives," said A.J. Cervantes, executive chairman. "In addition to his accounting expertise, his finance knowledge and experience will not only serve to support but help drive our proactive acquisition strategies."

Bonne Santé Group purchased Bonne Santé Natural Manufacturing in 2018. The company has more than 20 years of experience producing nutraceutical capsules and tablets for retailers and clients globally, including the United States, South and Central America, and Europe.

Regarding the new hire, BSG’s chief executive officer Ryan Zackon added: "I've known Alan since 2016 and I am pleased to welcome him to our leadership team. Alan's extensive experience in the complex space of domestic and cross-border acquisitions, paired with his deep understanding of the financial operations within publicly held companies will make an immediate impact as we move quickly through our robust target pipeline and continue to position the Bonne Santé Group for an IPO."